The renal elimination of procainamide

Area of Science:

• Pharmacology
• Nephrology
• Drug Metabolism

Background:

• Procainamide (PCA) is a medication used to treat cardiac arrhythmias.
• Understanding the renal elimination of PCA is crucial for safe and effective therapeutic use.
• The role of urine pH and flow rate in PCA renal clearance has been debated.

Purpose of the Study:

• To investigate the influence of urine pH and flow rate on the renal elimination of procainamide (PCA).
• To determine the primary mechanism of PCA renal excretion in humans.

Main Methods:

• Four subjects received intravenous procainamide (PCA) under four conditions: acid/alkali load and water deprivation/excess.
• Urine and plasma samples were collected for analysis of PCA and its metabolite N-acetyl PCA (NAPA).
• Renal clearance, urine flow rates, and urine pH were measured and analyzed.

Main Results:

• Urine flow rates varied significantly (1.2 vs 5 ml/min) and urine pH varied markedly (pH 5 vs 8).
• Despite these variations, there were no significant changes in renal clearance or 24-hour excretion of PCA and NAPA.
• These findings contradict the predictions of the pH partition hypothesis for passive diffusion.

Conclusions:

• Passive diffusion is not a significant mechanism for renal elimination of procainamide in humans.
• Renal elimination of PCA likely occurs via tubular secretion.
• Clinical dosing of procainamide does not require adjustment based on variations in urine flow or pH.